Stable Road Acquisition Corp. (SRAC) Made Misstatements Regarding its Business Prospects On October 7, 2020, Stable Road and Momentus issued a joint press release announcing that Stable Road had agreed

Orphazyme A/S (ORPH) Misstated the Efficacy of its Drug Arimoclomal in its IPO Offering Documents      Orphazyme held a public offering in September 2020 based on negligently prepared offering documents. 

360 DigiTech, Inc. (QFIN) Made False and Misleading Statements Regarding its Business, Operations, and Prospects    During the relevant period, defendants touted the Company’s dedication to privacy protections and data

Kanzhun Limited (BZ) Misled the Investing Public Regarding Its Cybersecurity Risks    On July 5, 2021, Kanzhun announced that it was “subject to cybersecurity review by” the Cyberspace Administration of

James River Group Holdings, Ltd. (JRVR) Misled the Investing Public Regarding the Impact of Uber on the Company’s Reserves   In 2014, James River entered into a novel agreement with

CarLotz, Inc. (LOTZ, LOTZW) Made False and Misleading Statements Regarding its Business, Operations, and Prospects    CarLotz, Inc. became a public entity via merger with Acamar Partners Acquisition Corp., a

Full Truck Alliance Co. Ltd. (YMM) Failed to Disclose it was the Subject of a Cybersecurity Review by the Chinese Government that Threatened the Company’s Ability to Operate and Grow

Frequency Therapeutics, Inc. (FREQ) Made Misstatements Regarding the Potential of its Hearing Loss Treatment FX-322   Frequency Therapeutics began its Phase 2a trial for FX-322 in October 2019.  The trial

Washington Prime Group, Inc. (WPG) Made Misstatements Regarding its Deteriorating Financial Condition During the class period, WPG failed to disclose material adverse facts about the Company’s business, operations, and prospects.